Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 7 November 2000
Vol. 2000, Issue 57, p. pe1
[DOI: 10.1126/stke.2000.57.pe1]


Meeting Report: Targeting Protein Phosphatases-Medicines for the New Millenium

Shirish Shenolikar1* and David L. Brautigan2

1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
2Departments of Microbiology and Medicine, Center for Cell Signaling, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

A review of the meeting Protein Phosphatases, FASEB Summer Research Conference, Copper Mountain, CO, 23 to 28 July 2000.

Abstract: Shenolikar and Brautigan summarize the key issues discussed at the conference on protein phosphatases of the Federation of American Societies for Experimental Biology (FASEB). A theme of the meeting was how basic research in the field of protein phosphatases has led to better understanding and treatments for human disease, including type 2 diabetes and obesity. A second important issue presented related to identification and characterization of various phosphatase-binding proteins that regulate phosphatase action.

Corresponding author. E-mail:

Citation: S. Shenolikar, D. L. Brautigan, Meeting Report: Targeting Protein Phosphatases-Medicines for the New Millenium. Sci. STKE 2000, pe1 (2000).

Read the Full Text

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882